Try our Advanced Search for more refined results
Life Sciences - October, 2010
186 articles
- Discovery Rule Applies To Stryker Pain Pumps: Judge
- Hikma Buys Baxter's Injectibles Business For $112M
- Novartis, Watson End Suit Over Enablex ANDA
- Chem Rx Auction Canceled Due To Low Bid Turnout
- Ex-Pfizer Exec Takes Genotropin Suit To 1st Circ.
- Sandoz Pulls Methotrexate Lots Over Vial Defects
- Merck Sets Aside $950M For Federal Vioxx Settlement
- AGA Medical Investor Sues Over $1.3B St. Jude Deal
- French Court Sides With Novartis In J&J Patent War
- DOJ, Attys Duel Over Sentence For Convicted Fraudster
- St. Jude Surgical Patent Withstands ACI Dismissal Bid
- Targeting Health Care Execs And Managers
- Ex-Safescript CEO Gets 30 Months For Insider Trading
- Zydus Fights For Right To Make Generic Strattera
- Neurovision Wins $60M Verdict In Trademark Suit
- 1 Size Doesn't Fit All In Patent Trials
- Creditors Fight Chem Rx's Asset Sale Plans
- Teva To Acquire Theramex in €265M Deal
- Shearman Reps Boston Sci In $2B Unit Sale To Stryker
- Customs Improperly Classified Surgical Lamps: CIT
- GSK Must Face Wellbutrin Consumer Antitrust Suit
- AstraZeneca Targets Watson Over Crestor NDA
- Pharmacists Group Loses Appeal Of EU Antitrust Raid
- Wyeth, Schwarz Escape Reglan Failure-To-Warn Suit
- Australian Watchdog Delays Aspen's Sigma Bid
- Novartis Sues Apotex To Block Generic Exelon
- Intel, Express Scripts Settle Row Over 'Intellact' Mark
- Motorola Latest Target In False Marking Suit Wave
- FDA Warns Drug Co. Over Misleading Info On Website
- Pfizer Faces Italian Antitrust Probe Over Xalatan Patent
- Bayer To Pay 3 States $3.3M To End Vitamin Claims
- GSK To Pay Record $750M Whistleblower Settlement
- FDA Warns Mead Johnson Over Enfamil Packaging
- Abbott, WARF Hit Anchen With Zemplar Patent Suit
- 2nd Circ. Quashes Philips Atty's Wrongful Firing Suit
- Amphastar Sues FDA Over Raw Heparin Shipments
- King Pharma Drug Reps Sue For Overtime Pay
- Actavis Recalls Pain Patches Over Dosage Fears
- US Attys Eye Canada As Fertile Class Action Ground
- Plaintiff Rejects New Verdict In Merck Fosamax Case
- Pharma Industry Dominates 2010 FCA Payouts
- Carlyle Weighs $3B Buyout Of CommScope
- Judge Tosses FCA Suit Against Medco Health
- Humana Tries To Snuff Qui Tam Medicare Fraud Case
- Occlutech Win In Dutch Feud With AGA Medical Stands
- Ex-Trader Still On Hook For Tips From Insider's Wife
- 1st Circ. Affirms Liability Of Infomercial Producers
- Winston & Strawn Nets Cadwalader M&A Pro
- Suit Says GE CT Scans Blast Patients With Radiation
- 9th Circ. Tosses Amgen Off-Label Marketing MDL
- FDA Issues Alert Over Chinese Crospovidone
- FDA Strengthens Warning Label On Roche HIV Drug
- 2nd Circ. Considers Reinstating Fosamax Witness
- Wyeth Loses Bid To Keep Effexor Deals Under Wraps
- Mentor Investors' Suit Over $1B J&J Merger Tossed
- Mylan Takes Bid For Paxil Injunction To 3rd Circ.
- DOJ, US Atty Subpoena GSK Over Avandia, HIV Drugs
- Judge Reverses Verdict In KCI Wound Therapy IP Suit
- Mutual, Hikma Settle Suit Over Unapproved Gout Drug
- ProThera Must Face Merck Unit's Folate Ad Claims
- FDA Wants New Warnings On Prostate Cancer Drugs
- Prempro Use May Double Breast Cancer Risk: Study
- Lilly Sues Accord Over Gemzar ANDA
- Mylan Attacks Newly Issued Oracea Patent
- 8th Circ. To Rehear Catheter Antitrust Suit Against Bard
- Skadden Reps Pfizer In $240M Deal For Teuto Stake
- Common Benefit Attys To Get $315M From Vioxx Deal
- Nurse, Dr.'s Sentences Upheld In Medicare Scam Case
- McKesson To Pay Conn. $15M To Settle AWP Suit
- Pfizer Cleared In $3.5M Prempro Trial
- Fosamax Plaintiff's Attorney Appeals Sanctions
- J&J Unit Recalls More Tylenol For Musty Odor
- Pharmacy Seeks To Send Provigil Suit To State Court
- Wellbutrin Users Seek To Revive Class Cert. Bid
- Baxter Settles Lab Tech OT Action For $2.6M
- Prosecutors Refuse To Give FDA Docs To Stryker
- Colgate Fires Back In GSK's Toothpaste IP Suit
- Sanofi, Bristol-Myers Win $442M In Plavix Patent Suit
- Patent Reform's Effects On Hatch-Waxman Litigants
- FDA Panel OKs Use Of Anemia Drugs, Despite Study
- Idaho Settles AWP Claims With Sandoz For $1.7M
- Genzyme Hits Medicis With IP Suit Over Wrinkle Fillers
- Supreme Court Rebuffs Spat Over Wound Therapy IP
- Gibson Dunn Reps St. Jude In $1.3B AGA Medical Deal
- King's Board Cashing In On $3.6B Pfizer Deal: Suit
- Nigerians Win Discovery Bid In Suits Over Pfizer Trials
- 'Printed Publications' In A Digital Age
- SEC Wins Fraud Suit Against Troubled Drug Co.
- 6th Circ. Won't Rehear Wyeth Diet Pill Case En Banc
- 8th Circ. Affirms Preemption Ruling In Medtronic MDL
- DOJ Antitrust Division Enlists Cravath Partner
- Teleflex Can't Toss All Claims In Kan. Cleanup Fight
- Warner Chilcott, Lupin Settle Birth Control IP Dispute
- Pozen's Suit Over Treximet ANDAs Stays Intact
- La. Jury Hits J&J With $258M Verdict In Risperdal Suit
- 5 Tricks For Deposing A Class Certification Expert
- UK Fines Reckitt $16M For Thwarting Generic Meds
- FDA To Assess Anemia Drug Risks In Kidney Patients
- FDA To Yank Marketing Approval For Menaflex Device
- AARP Joins Whistleblower Suit Against Stent Makers
- CVS To Pay $75M For Admitted Sale Of Meth Ingredient
- KV Settles Promote Innovation False Marking Suit
- Ivera Sues Hospira Over Medical Cleaning Patent
- US Wins Bid To Intervene In Qui Tam Wyeth Drug Suit
- The FDA's New New Drug Safety Reporting Plan
- Medtronic Settles Sprint Fidelis MDL For $268M
- EPA Ups Ethanol Allowance, Draws Ire From Both Sides
- 1st Circ. Overturns Toss Of Genzyme D&O Coverage Suit
- Howmedica Polymers Patents Invalid: Fed Circ.
- St. Jude Tries To Block BSC's Poached Worker Suit
- FDA To Revise Warning Label On Bone Drugs
- Celgene Sues Natco To Block Generic Revlimid
- House Reps Call For Balance In 510(k) Overhaul
- 3rd Circ. Says Suit Over HIV Drug IP Belongs In France
- 4 Steps To Take When Your Client Gets Subpoenaed
- A Securities Litigator's Guide To D&O Insurance, Part I
- Cobalt Released From Sepracor Suit Over Sleep Drug
- High Court Weighs Vaccine Injury Preemption
- Teva Fails To Uncover Plans For Generic Copaxone
- Merck Targets Experts In Next Fosamax Bellwether
- Becton Fights Antitrust Claims By Rival Syringe Maker
- Roche Fires Back At SG In Contractor IP Rights Case
- High Court Snubs Drug Cos.' Appeal Of HRT Cases
- Impax Settles Cephalon Suit Over Generic Amrix
- Cadwalader Reps Pfizer In $3.6B King Pharma Buy
- Russian Court Nixes Plastic Co.'s Competition Case
- Pfizer To Pay $3.8M Over Girl's Death In Dilantin Suit
- Mayer Brown Nabs Solvay Pharma GC
- Purdue Sues Hospira To Block New Version Of Dilaudid
- Avandia ERISA Class Actions Consolidated
- Tensions Simmer In Sanofi, Genzyme Bid Battle
- Takeda, Wockhardt Settle Feud Over Generic Actos
- Abbott To Pull Meridia In US Over Heart Risks
- FDA To Revamp Regulatory Science Agenda
- Settlement Docs Off-Limits In Rituxan Fraud Suit
- New DataTern IP Suit Targets Aflac, Lilly, Others
- Novartis Prevails In 2nd Trial Over Bone Drug Liability
- Pfizer Recalls 191,000 Lipitor Bottles Due To Odor
- Cravath, Weil Advise J&J In €1.75B Offer For Crucell
- Conceptus Waived Privilege For Prior Art Letter: Judge
- Volcano Can Use Confidential Info In Secrets Spat
- Angiotech Accused Of Breaching Quill Merger Deal
- Endo, Watson Settle Litigation Over Opana ER Generic
- Chem Rx's Bidding Procedures, Breakup Fee OK'd
- Consumers Target J&J Unit Over Listerine Marketing
- The Patent System Pendulum Revisited
- Pfizer Hits Lupin With 2nd Suit Over Lyrica ANDA
- Indirect Wellbutrin Buyers Denied Cert. Against GSK
- Allergan Sues Watson, Paddock Over Generic Sanctura
- Fed. Circ. Revives Teva's Suit Over Aricept Patents
- Novo Can't Shake Bid To Invalidate Prandin Patent
- Brazilians' Enviro Claims Don't Stand In US, Judge Says
- Chinese Co. Shells Out $7.5M For Illegal HGH Sales
- Coke, LG, Others Targeted In Web Data Patent Suit
- Generic Preemption Issue At Play In 9th Circ.
- Toshiba, Wistron Settle Laptop Patent Dispute
- Trubion Investor Sues To Halt $135M Sale To Emergent
- Teva Sues Mylan, Others Over Proposed Azilect Generic
- CB Richard Says Workers In China Paid Local Officials
- 3 Perrigo Board Members Walk From ARS Class Suit
- Stryker Says FDA Has Docs That Will Exonerate It
- Lilly Targets Dr. Reddy's Over Gemzar ANDA
- FDA Warns Gilead Over Drug Plant Problems
- Judge Merges Suits Over Provigil Pay-For-Delay Deals
- 2nd Circ. Axes 8 Zyprexa Suits Against Eli Lilly
- Trust Your Doctor, Not The 'Net
- Character Testimony Bid Nixed In Insider Trading Case
- Synthes To Pay $24M For Illegal Bone Cement Tests
- Judge Cuts Fosamax Award From $8M To $1.5M
- Sanofi Takes $18.5B Bid To Genzyme Shareholders
- Streck Triumphs In Hematology IP Fight Against Rival
- Chem Rx Gets More Time To File Ch. 11 Plan
- Gilead Sues Sigmapharm Over Hepatitis B Generic
- Supreme Court Asks US To Weigh In On Loss Causation
- FDA Seeks More Info On J&J's New Pain Drug
- How New USPTO Guidelines Clarify Obviousness Issues
- How Certain Products Can Be The Same, But Different
- Naturex Agrees To Stop Violating Mars Flavanol Patents
- Walgreen Beats Shareholder Suit Over Analyst Report
- Medtronic Settles Patent Spat Over Stents
- UK Court To Hear AstraZeneca's $10M Contract Suit
- Jury To Decide Roche Battle Over Generic Boniva
- AstraZeneca Targets Torrent Again Over Seroquel ANDA
- Lead Plaintiff In Eli Lilly FLSA Suit Still Out
- Pharmacy Class Blasts CVS For Misusing Patient Info
- Guide Flow Sues Bard, Others Over Catheter Patent